It’s not a secret that our prescription drug pricing system is broken. To address the root of the problem, the Biden administration recently convened a listening session seeking insights from experts on substantive solutions to improve patient access and affordability.
Rightly so, the session focused primarily on the adverse effects of restrictive policies implemented by health insurance and pharmacy benefit managers (PBMs). Patients and consumers still grapple with the issue. These policies limit access to crucial medicines and treatments, resulting in delayed wellness and increased financial burdens.